Michael A. Morgan

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Journal: Scientific reports
Published: May 15, 2026

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Journal: Frontiers in immunology
Published: February 05, 2025

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Journal: Frontiers in immunology
Published: August 23, 2024

Alpharetroviral Vector-Mediated Gene Therapy for IL7RA-Deficient Severe Combined Immunodeficiency.

Alpharetroviral Vector-Mediated Gene Therapy for IL7RA-Deficient Severe Combined Immunodeficiency.

Journal: Human gene therapy
Published: August 16, 2024

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer.

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer.

Journal: Scientific reports
Published: June 12, 2024

Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.

Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: December 06, 2023

Prime time for base editing in the mitochondria.

Prime time for base editing in the mitochondria.

Journal: Signal transduction and targeted therapy
Published: May 17, 2022

NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44.

NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44.

Journal: Biomedicines
Published: August 28, 2021

Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy.

Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy.

Journal: Frontiers in immunology
Published: July 31, 2021

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.

Journal: Viruses
Published: June 04, 2021

Targeted cytokine delivery: cell therapy to remodel the pre-metastatic niche.

Targeted cytokine delivery: cell therapy to remodel the pre-metastatic niche.

Journal: Signal transduction and targeted therapy
Published: May 26, 2021

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients.

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients.

Journal: Scientific reports
Published: April 26, 2021
Showing 1-12 of 29

Last Updated: 09/26/2026